Introduction
Plasminogen activator inhibitor-1 (PAI-1) is the major regulator of both tissue and urokinase plasminogen activators 1, 2 . Inhibition of plasminogen activation by PAI-1 reduces the generation of plasmin and thereby impairs fibrinolysis. In addition, PAI-1 has also been suggested to reduce plasmin-mediated activation of matrix metalloproteases 3 and compete with cellular αvβ3 integrin matrix interactions, which contribute to cellular migration 4 . Overexpression of PAI-1 in transgenic mice or by adenovirusmediated gene transfer increases thrombosis 5, 6 and PAI-1 deficiency enhances fibrinolysis and neointimal remodeling 7, 8 . Increased levels of PAI-1 have been demonstrated in vascular lesions induced by balloon catheter injury and atherosclerosis [9] [10] [11] [12] . Within these vascular lesions, PAI-1 expression is prominently increased in neointimal smooth muscle cells 9, 13 . In previous animal studies using angiotensinconverting enzyme inhibition, angiotensin type 1 receptor antagonism and systemic angiotensin II (Ang II) infusion, our group and others have demonstrated that the Ang II/AT 1 pathway plays an important role in regulating vascular PAI-1 gene expression in vivo 9, [14] [15] [16] .
A host of agonists, including Ang II, transforming growth factor-β (TGF-β), very low density lipoprotein (VLDL), and phorbol ester, require the activity of MAPK/ERK kinase1 and 2 (MEK1,2) to induce PAI-1 mRNA expression [17] [18] [19] [20] . While the MEK/ERK pathway plays a key role in controlling PAI-1 mRNA levels, the mechanism(s) which mediates MEK1,2's effects on PAI-1 transcription have not been identified. Previous reports have demonstrated that the MEK/ERK pathway can affect phosphorylation,
For personal use only. on October 31, 2017 . by guest www.bloodjournal.org From nuclear transport, and transactivation of a number of transcription factors, including Elk-1, SMAD, c-Jun, Sp1, and STAT3 [21] [22] [23] [24] [25] . In addition, Ras/MEK/ERK activation can lead to increased expression of intermediate-early response genes, such as c-fos, egr-1, and junB 26 . While the promoter of the PAI-1 gene contains an array of potential response elements for these transcription factors [27] [28] [29] 
Materials and methods

Materials
Dominant negative AP-1 (A-Fos), and CREB (A-CREB) expression vectors were provided by Dr. Charles Vinson 30, 31 . pCMV-Sp1 was a gift from Dr. Jonathan Horowitz.
pCMV-c-Jun was provided by Dr. Tom Curran. pRSV-c-Fos was a gift from Dr. Ronald
Law. Plasmids for constructing adenovirus were gifts from Dr. George King. cDNA of constitutively active MEKK-1 was obtained from Stratagene (La Jolla, CA). pAPFor personal use only. on October 31, 2017 . by guest www.bloodjournal.org From 1(PMA)-TA-Luc was purchased from Clontech Laboratories (Palo Alto, CA). PD98059, SP600125, SB203580 and Y27632 were purchased from Calbiochem (La Jolla, CA).
Angiotensin II was purchased from Sigma-Aldrich Co. (St. Louis, MO). Candesartan CV 11974 was kindly provided by Dr. Peter Morsing (Astra Hassle AB, Mölndal, Sweden).
Cell culture
Vascular smooth muscle cells were isolated from aortic explants from SpragueDawley rats, cultured in Dulbecco's Modified Eagle Medium with 10% fetal bovine serum (Invitrogen, Carlsbad, CA) as described previously 32 .
RNA isolation and northern blot analysis
Cells were serum starved in medium containing 0.1% BSA overnight and then stimulated with 100 nM Ang II for three hours. Total RNA was isolated using TRI REAGENT (Molecular Research Center, Cincinnati, OH). RNA was separated by agarose gel electrophoresis and expressions of PAI-1, luciferase and acidic ribosomal phosphoprotein (36B4) mRNA levels were determined by northern analysis, as described previously 32 . Levels of mRNA expression were visualized and quantitated by PhosphorImager analysis (Molecular Dynamics Inc., Sunnyvale, CA).
Plasmids and adenoviruses construction
Rat PAI-1 promoter -1800, -764 were isolated from rPAI-CAT(-1800) and rPAI- 4 /Luc. A series of mutation was also constructed as for (MRE) 2 /Luc using synthetic oligonucleotides containing trinucleotide substitutions of MRE (Invitrogen). All constructs were confirmed by sequencing (DNA Core Facility, Joslin Diabetes Center, Boston, MA). To generate adenoviruses, the Mlu I (5') to Bam HI (3') fragments of PAI-1(-88)/Luc and PAI-1(-50)/Luc, and the Nhe I (5') to Bam HI (3') fragments of PAI-1(-764)/Luc and the control vector, pGL3-enhancer, were inserted into pAdTrack and followed the instruction of AdEasy System 33 .
Reporter gene assay
VSMC at about 70% confluence were starved in OPTI-MEM medium (Invitrogen) for overnight. Cells were then transfected with plasmids using Lipofectamine or Lipofectamine 2000 (Invitrogen) and harvested twenty-four hours after the start of transfection. Luciferase activities were assayed using Dual Luciferase Reporter Assay System (Promega), and adjusted for transfection efficiency by normalizing firefly
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Nuclear protein extraction, pull-down assay and co-immunoprecipitation
Confluent VSMC were serum starved overnight and then stimulated with 100 nM Ang II. Aortas were collected from male Sprague-Dawley rats with one hour intrajugular vein infusion of saline or Ang II (100 ng/kg/min), as described previously 14 . Nuclear protein extraction was performed as previously described 34 for Sp1-AP-1 association assay, or using Nuclear Extract Kit (Active Motif, Carlsbad, CA) for pull-down assay.
Double-stranded biotin-labeled MRE oligonucleotides (wild type:
5'CAGAGTTAGAAGGTGGGTGGGGCTGGAACATGAGTTCATCTA3'; mutant:
5'CAGAGTTAGAAGGTGGGAGTCAGTGGAACAGTCAGTCAGTCA3') (Invitrogen) bound to Streptavidin-agarose beads (Pierce, Rockford, IL) was incubated with 25 µg nuclear extract in gel shift binding buffer (Promega). The beads were then washed three times and boiled in sample buffer. Bound proteins were assayed by western blot analysis using anti-c-Fos, anti-c-Jun, and anti-Sp1 antibodies (Santa Cruz, Santa
Cruz, CA). For co-immunoprecipitation, 200 µg of nuclear extracts were immunoprecipitated with anti-Sp1 antibody-conjugated agarose (Santa Cruz) in 300 µl immunoprecipitation buffer as previously described except no NaCl was used 35 . Sp1 and c-Jun content in immunoprecipitates were then quantitated by western blot analysis.
Statistics
All statistical analyses were performed by one way analysis of variance (ANOVA)
using SigmaStat (Jandel Scientific 37, 38 . In addition to the MEK/ERK pathway, MEKK-1 also activates stress MAP kinase pathways by phosphorylating MKK4 and MKK7, which leads to the activation of the c-Jun N-terminal kinase (JNK) pathway 39, 40 , and by phosphorylating MKK3 and MKK6, which leads to p38 MAP kinase activation 41 . To examine the involvement of these MAP kinase pathways on PAI-1 promoter activity, the effects of upstream activation of these pathways using a constitutively active MAP kinase kinase kinase-1 (MEKK-1*) on PAI-1 promoter/luciferase reporter gene constructs were investigated.
A series of 5' deletion of PAI-1 promoter/Luc constructs were generated to identify PAI-1 promoter sequence(s) that mediates PD98059-sensitive MEKK-1 response. To further investigate the enhancer properties of the MEKK-1 response element (MRE), the MEKK-1 stimulation of this isolated sequence was examined. The MRE sequence was inserted upstream of the SV40 promoter in the pGL3 vector to create an MRE/Luc construct. In addition, multimers of the MRE were also generated to form (MRE) 2 /Luc and (MRE) 4 /Luc reporter constructs, containing 2 and 4 copies of this MRE, respectively. The presence of MRE, (MRE) 2 , and (MRE) 4 did not affect basal activity of SV40 promoter. However, MEKK-1 activation stimulated the MRE response in a copy number dependent manner, increasing luciferase activity from 2.5 fold for MRE/Luc to 5.7 fold for (MRE) 2 /Luc, and 24 fold for (MRE) 4 /Luc (Fig. 2 ). Since MEKK-1 is upstream activator of MEK1,2, JNK and p38 pathways, we further investigated which pathway was responsible for the activation of this region. The involvement of AP-1 and Sp1 binding proteins in MEKK-1-stimulated MRE activation was further examined using the wild type (MRE) 2 /Luc construct. Cotransfection of plasmids expressing Sp1, A-Fos, or control plasmid (pCMV) did not affect (MRE) 2 /Luc basal activity (Fig. 4) . However, co-transfection of these expression (Fig. 4) , suggesting that AP-1 is essential for Sp1 effects. For (Fig. 6A and B) . In addition, Ang IIstimulation in the presence of candesartan did not significantly increase Sp1 binding to the MRE compared with cells treated with candesartan alone (Fig. 6C ).
Since treatment of cells with the MEK 1,2 inhibitor PD98059 reduced Ang IIstimulated PAI-1 mRNA expression by 78%, the roles of the MEK1,2 pathway in AP-1 and Sp1 binding to the MRE were investigated. (Fig. 6C) . To further characterize the signaling pathways involved in Ang II's effects on the MRE, the role of the Rho-kinase pathway was investigated. The Rho-kinase activity has been previously shown to be required for Ang II-induced PAI-1 mRNA expression in rat VSMC and in heart ventricle from Ang IIinduced hypertensive rats 17, 44 . Using a reporter gene approach, we identified an MEKK-1 response element (MRE)
in the rat PAI-1 promoter, which is located from -88 to -51 bps relative to the transcription start site. A previous report has shown that activation of MEKK-1 can increase PAI-1 promoter activity in endothelial cells 45 . Although a number of response elements have been identified in the region between -764 and -88 [46] [47] [48] , this region does not appear to play a critical role in the activation of the PAI-1 promoter by MEKK-1.
Since the MEKK-1 activation of the MRE was completely blocked by MEK1,2 inhibition The physiological relevance of Ang II's effect on the MRE was examined using nuclear extracts isolated from rat aortas. One hour Ang II intravenous infusion in rats induced aortic c-Fos binding to the MRE by 17 fold, which was comparable with the robust c-Fos response to Ang II from cultured VSMC. In addition, aortic c-Jun and Sp1 binding to the MRE was observed in rats subjected to either saline or Ang II infusion.
These in vivo studies show that rat aortic c-Fos, c-Jun, and Sp1 bind to the MRE. Among these factors, Ang II induced a significant increase in c-Fos/MRE association using nuclear extracts from aorta and cultured VSMC. These results suggest that the c-Fos response on the MRE plays an important role in activating the PAI-1 promoter both in vivo and in vitro.
In this report, we showed that the AT 1 antagonist in affecting plasma PAI-1 could be related to the etiology for the increased PAI-1 levels in a particular group of subjects and/or the specific antagonist used. In regards to the latter, our group has shown that losartan partially blocks Ang II induced PAI-1 in VSMC whereas candesartan completely blocks this response 14, 32 . Although AT 1 antagonism decreases aortic and cardiac PAI-1 expression in rats [14] [15] [16] , the effects of AT 1 blockage on PAI-1 expression in human vascular tissues in vivo remain to be
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From determined. Moreover, the relative contribution of PAI-1 derived from vascular tissues to the total pool of plasma PAI-1 is unknown.
Using adenovirus for gene transfer, we demonstrate that the 38 base pairs MRE region of PAI-1 promoter is accountable for its response to Ang II stimulation. In addition, the involvement of MEK1,2 pathway in the activation of the MRE region is also confirmed by PD98095 inhibition. Previously, the sequences of PAI-1 promoter which functionally respond to the stimulation of TGF-β, Ang II, glucose, glucosamine and fatty acid were reported 50, [52] [53] [54] 63 . However, the sequence which mediates PAI-1's response to Ang II stimulation in VSMC was not reported, partially due to low transfection efficiency of primary cell culture by cationic lipids reagents such as Lipofectamine, about 5% maximum based on estimate from transfected GFP expressing cells (data not shown), and could only generate <50% response to Ang II stimulation during transient transfection 17 .
Using adenoviral vectors we were able to infect >80% of cells with PAI-1/Luc reporter constructs and show that Ang II's effect on the MRE region is comparable to its effect on endogenous PAI-1 mRNA.
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